Company Encyclopedia
View More
name
Core Laboratories Luxembourg SA
CLB.US
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
277.06 B
CLB.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Energy Equipment and ServicesIndustry
Industry Ranking43/66
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE12.31%B
    • Profit Margin6.21%B
    • Gross Margin22.02%D
  • Growth ScoreC
    • Revenue YoY-1.02%D
    • Net Profit YoY22.63%B
    • Total Assets YoY-1.52%D
    • Net Assets YoY8.18%B
  • Cash ScoreC
    • Cash Flow Margin1610.95%B
    • OCF YoY-1.02%D
  • Operating ScoreB
    • Turnover0.87B
  • Debt ScoreC
    • Gearing Ratio53.09%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Treas Teo Acquires 524 Of Core Laboratories Inc [CLB]

    Teo Sow Hang, Officer and Treasurer of Core Laboratories Inc [CLB], filed a Form 4 on December 2, 2025, with the SEC disclosing changes in ownership. Transactions included the exercise of 864 shares and the surrender of 1,340 shares at $15.39 each. Ending holdings are 8,765 shares directly. The surrender was to cover option exercise costs and/or tax liabilities.

    Reuters·
    US
    CLB
    +0.43%
    Reuters·
    US
    CLB
    +0.43%

    Core Laboratories (NYSE:CLB) Announces Quarterly Earnings Results

    Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share, exceeding estimates of $0.18. The company had a net margin of 5.73% and a return on equity of 14.15%, with revenues of $134.52 million. Core Laboratories also announced a quarterly dividend of $0.01, payable on November 24. Institutional investors hold 97.81% of the stock, and analysts have mixed ratings, with a consensus price target of $12.50. The stock opened at $12.81, with a 12-month range of $9.72 to $21.83.

    Market Beat·
    US
    CLB
    +0.43%
    Market Beat·
    US
    CLB
    +0.43%

    CORE LAB REPORTS THIRD QUARTER 2025 RESULTS | CLB Stock News

    Core Laboratories Inc. reported third quarter 2025 revenue of $134.5 million, a 3% sequential increase, with operating income of $20.9 million. GAAP EPS was $0.30, while ex-items EPS was $0.22. The company repurchased 462,248 shares and generated free cash flow of $6.5 million. Core Lab also announced a quarterly dividend and completed the acquisition of Brazil-based Solintec to enhance its geological services. The company noted strong demand for its services, particularly in the Asia-Pacific region, and improved its leverage ratio to 1.10.

    StockTitan·
    US
    CLB
    +0.43%
    StockTitan·
    US
    CLB
    +0.43%

    Core Laboratories Announces Q3 2025 Financial Results

    Core Laboratories (CLB) announced its Q3 2025 financial results, reporting revenue of $134.5 million, a 3% sequential increase but flat year-over-year. The company achieved an operating income of $20.9 million and a GAAP EPS of $0.30. Core Lab acquired Solintec, repurchased shares, and declared a cash dividend, improving its leverage ratio to a nine-year low. Analysts rate CLB stock as a Hold with a $13.00 price target, while Spark's AI Analyst views it as Neutral, citing strong performance but potential short-term weakness.

    Tip Ranks·
    US
    CLB
    +0.43%
    Tip Ranks·
    US
    CLB
    +0.43%

    Bank of America Securities Reaffirms Their Sell Rating on Core Laboratories (CLB)

    The word on The Street in general, suggests a Hold analyst consensus rating for Core Laboratories with a $12.33 average price target.

    Tip Ranks·
    US
    CLB
    +0.43%
    Tip Ranks·
    US
    CLB
    +0.43%
    © 2025 Longbridge｜Disclaimer